Arrowhead Research announced that it has named David Lewis as its vice president of biology, and David Rozema as its vice president of chemistry.
Lewis and Rozema recently joined Arrowhead through the company's recent acquisition of Roche's Madison, Wis.-based RNA therapeutic operations (GSN 10/27/2011).
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
